Redeye reiterates its positive long-term stance on Artificial Solutions (AS) on the back of a mixed Q2-report, the key highlights of which was the sales and EBIT beat and the continued surging usage of Teneo solutions. However, order intake and order backlog was less encouraging due to challenges related to the pandemic. The report motivates minor estimates revisions while the dilution from the recent share issue yields a slightly lower base case.